Many therapies are administered as a "bolus" or one-time dose, but they may also be administered as an extended infusion or drip
the FDA itself hasn't formally loosened restrictions yet. The vote came from the PCAC, not the FDA, and their recommendation is strictly advisory, not legally binding. According to Holt, nothing changes for consumers right now simply because the PCACs vote is an advisory one
If you have experienced skin reactions with copper peptide serums, see Copper Peptides Ruined My Skin and Copper Peptide Irritation Guide for troubleshooting
Drawing BAC Water into the Syringe New sterile syringes reduce contamination during medication preparation
Always follow the dosage instructions provided on the product label and consult a healthcare professional if you have specific concerns
Learn how your genes impact lead levels, and what to do about it